Michael at 15:00, 15 September 2025

2025-09-15T15:00:20Z

← Older revision		Revision as of 15:00, 15 September 2025
Line 2:		Line 2:

	==Loss of staining==		==Loss of staining==
	*[[Malignant mesothelioma]]		*[[Malignant mesothelioma]] -ve<ref name=pmid29085180>{{cite journal \|authors=Pulford E, Huilgol K, Moffat D, Henderson DW, Klebe S \|title=Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis? \|journal=Dis Markers \|volume=2017 \|issue= \|pages=1310478 \|date=2017 \|pmid=29085180 \|pmc=5612603 \|doi=10.1155/2017/1310478 \|url=}}</ref> ~57%.<ref name=pmid26226841>{{cite journal \|authors=Andrici J, Sheen A, Sioson L, Wardell K, Clarkson A, Watson N, Ahadi MS, Farzin M, Toon CW, Gill AJ \|title=Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology \|journal=Mod Pathol \|volume=28 \|issue=10 \|pages=1360–8 \|date=October 2015 \|pmid=26226841 \|pmc=4761613 \|doi=10.1038/modpathol.2015.87 \|url=}}</ref>

	==Normal staining==		==Normal staining==
	*[[~~BAP1~~]] retained (normal) nuclear staining ~~in [[well~~-differentiated papillary mesothelial ~~tumour]]~~.<ref ~~name=pmid35440764/~~>		*[[Well-differentiated papillary mesothelial tumour]] - retained (normal) nuclear staining.<ref name=pmid35440764>{{cite journal \|authors=Churg A, Galateau-Salle F \|title=Well differentiated papillary mesothelial tumor: a new name and new problems \|journal=Mod Pathol \|volume=35 \|issue=10 \|pages=1327–1333 \|date=October 2022 \|pmid=35440764 \|doi=10.1038/s41379-022-01082-y \|url=}}</ref>

	==See also==		==See also==

Michael: Created page with "'''BAP1''', an abbreviation of '''BRCA1-Associated Protein 1''', is an immunostain that is used in the diagnosis of malignant mesothelioma.{{cite journal |vau..."

2025-09-15T14:57:14Z

Created page with "'''BAP1''', an abbreviation of '''BRCA1-Associated Protein 1''', is an immunostain that is used in the diagnosis of malignant mesothelioma.<ref>{{cite journal |vau..."

New page

'''BAP1''', an abbreviation of '''[[BRCA1]]-Associated Protein 1''', is an [[immunostain]] that is used in the diagnosis of [[malignant mesothelioma]].<ref>{{cite journal |vauthors=Louie BH, Kurzrock R |title=BAP1: Not just a BRCA1-associated protein |journal=Cancer Treat Rev |volume=90 |issue= |pages=102091 |date=November 2020 |pmid=32877777 |pmc=7655689 |doi=10.1016/j.ctrv.2020.102091 |url=}}</ref>

==Loss of staining==
*[[Malignant mesothelioma]]

==Normal staining==
*[[BAP1]] retained (normal) nuclear staining in [[well-differentiated papillary mesothelial tumour]].<ref name=pmid35440764/>

==See also==
*[[Claudin-4]].
*[[HEG1]].

==References==
{{Reflist|2}}

[[Category:Immunohistochemistry]]

BAP1 - Revision history

Michael at 15:00, 15 September 2025

Michael: Created page with "'''BAP1''', an abbreviation of '''BRCA1-Associated Protein 1''', is an immunostain that is used in the diagnosis of malignant mesothelioma.{{cite journal |vau..."